We're very close to a $17 print now.....with the new efficacy results and the MS upgrade, we're extremely undervalued.....
Interesting, because all three have FDA results this week, although the SRPT and ICPT pdufa results should have more of a material effect on their respective stocks, as they're a make or break decision,
With a normal stock, the gap would have some relevance, i.e. resistance after the gap is filled....Of course, RLYP is no longer a normal stock.
Keeping it simple. Well over $16 as I type. Berens sees the handwriting on the wall. I'm in the delay camp with others here, i.e. a ZS delay, with "more information" required. I've seen that FDA movie before, and AZN won't like it. If ZSPH were still a listed stock, that news would absolutely crater the stock. This should be an interesting week for RLYP longs!
This upgrade should be on my broker's news feed, but I don't see it yet. Also I'm trying to find Beren's full report or some color on the decision...anyone have that yet?
Just....that's huge; the biggest bear on the street finally caved in.....And now with this brand new efficacy news release, Thursday's ZS decision is not as significant, in my opinion, because RLYP can easily go it alone....but I still think the arbitrage players believe RLYP will be acquired at some point.
Exactly, and most who saw the Big Short just dismiss it as entertainment, and don't care about the implications, but you and know better.
Clown show is a good way of describing the blatant, incessant manipulation that goes on in every market, options, oil, heavily shorted names, all of it.. It's just amazing how the SEC doesn't get involved with any part of the clown show.
and now I can't pull it up, the link no longer works. Gee, I wonder why. On a related note, I think we'll test $16 on Monday or Tuesday. It'll be really interesting to see how RLYP trades up to Thurs.
This is the part where you wish you had unlimited funds at your disposal. Memo to longs...in this scenario, you really don't want to sell, even with the run up. It's obvious to me with the volume, a fund is taking a large position early, before the real fireworks....all in my opinion of course.
1. The Kremer's integration is going well, and they're still negotiating with the client Kremers lost, to bring them back
2. Even without no. 1 above, they already feel they're close to replacing that customer's revenue
3. They recently announced a huge partnership to develop the generic insulin market, a market in the billions
4. They were very upbeat on the recent ER call
5. Some analysts believe LCI could be a great M&A candidate, fitting in nicely with a larger generic player's acquisition strategy.
6. Technically the stock broke out late last week, so now you have some health care funds getting in early
Did I leave anything out?
Read my thread below yours....I think something big is up, or as I've suggested the market is repricing this stock quickly, as it's very undervalued.
In fact, there may be more going on than we're currently aware of, e.g. the arbitrage guys getting the heads up on an M&A play....
The technical indicators continue to turn up. Yesterday's supply was met with immediate demand, and the trend continues today (Friday). It looks like we could trade close to $24 by as soon as next week.